Dr. Reddy's Laboratories Limited — Updates, 16-09-2025: Press Release
16-09-2025 | 05:13 pm
16-09-2025 | 05:13 pm
Dr. Reddy's launched PCAB® (Tegoprazan) in India, a novel molecule for acid-related gastrointestinal diseases. This next-gen potassium-competitive acid blocker, from its partnership with HK inno.N, aims to address significant patient needs.
No comments yet. Be the first to comment!
